Andrea Loewen, SVP, Global Regulatory Affairs at REATA PHARMACEUTICALS INC (RETA), sold 6,350 shares at $172.03 ($1.1M) on 2023-09-14, disclosed to the SEC on 2023-09-18.
Open-market sale of $1.1M RETA by SVP, Global Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $172.03 | 3,175 | $546K | 50.0% |
| 2 | $172.03 | 3,175 | $546K | 50.0% |
| Total | $172.03 avg | 6,350 | $1.1M | 100% |
| Filing → |
| RETA | SELL | 2023-03-06 | $301K | — | Filing → |